| (Values in U.S. Thousands) | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -175,850 | -38,990 | -24,070 | -30,910 | -24,640 |
| Net Income Growth | -351.01% | -61.99% | +22.13% | -25.45% | +19.92% |
Soleno Therapeutics Inc (SLNO)
48.49 x 2 55.00 x 2
Post-market by (Cboe BZX)
49.11 +0.71 (+1.47%) 03/21/25 [NASDAQ]
48.49 x 2 55.00 x 2
Post-market 49.11 unch (unch) 16:55 ET
for Fri, Mar 21st, 2025
Soleno Therapeutics Inc. is a healthcare company. It develops and commercializes diagnostics, devices and therapeutics addressing unmet medical needs. The Company offers products consists of CoSense end-tidal carbon monoxide Monitor, NeoPIP Infant Resuscitator and Accessories and Serenz Nasal Relief. Soleno Therapeutics Inc., formerly known as Capnia Inc., is based in Vancouver, Canada.
Fiscal Year End Date: 12/31